Won-Ki Kim Selected Research

Dextrorphan

5/2004	Dimemorfan prevents seizures induced by the L-type calcium channel activator BAY k-8644 in mice.
1/2003	Metabolism to dextrorphan is not essential for dextromethorphan's anticonvulsant activity against kainate in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Won-Ki Kim Research Topics

Disease

11	Ischemia 01/2022 - 09/2003
11	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2022 - 09/2004
10	Seizures (Absence Seizure) 08/2011 - 12/2002
9	Stroke (Strokes) 01/2022 - 04/2006
8	Infarction (Infarctions) 06/2016 - 09/2004
7	Inflammation (Inflammations) 01/2022 - 04/2005
6	Ischemic Stroke 01/2022 - 05/2011
5	Cerebral Infarction 01/2022 - 05/2011
5	Brain Ischemia (Cerebral Ischemia) 01/2022 - 09/2004
5	Mitochondrial Diseases (Mitochondrial Disease) 12/2017 - 02/2009
5	Parkinson Disease (Parkinson's Disease) 12/2013 - 12/2006
5	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2013 - 08/2004
4	Neoplasms (Cancer) 05/2021 - 01/2006
4	Atherosclerosis 12/2019 - 08/2012
3	Edema (Dropsy) 01/2022 - 03/2013
3	Bipolar Disorder (Manic Depressive Psychosis) 12/2017 - 11/2015
3	Epilepsy (Aura) 08/2011 - 05/2008
3	Hypoxia (Hypoxemia) 02/2011 - 01/2006
3	Spinal Cord Ischemia 07/2006 - 10/2004
3	Astrocytoma (Pilocytic Astrocytoma) 04/2006 - 10/2005
2	Cerebral Hemorrhage 01/2022 - 01/2020
2	Brain Injuries (Brain Injury) 01/2022 - 01/2006
2	Obesity 01/2022 - 05/2010
2	Hyperplasia 01/2019 - 01/2017
2	Brain Diseases (Brain Disorder) 12/2017 - 08/2010
2	Schizophrenia (Dementia Praecox) 12/2017 - 11/2015
2	Cognitive Dysfunction 07/2013 - 06/2013
2	Neuroinflammatory Diseases 07/2008 - 07/2008
2	Brain Neoplasms (Brain Tumor) 01/2006 - 10/2005
1	Insulin Resistance 01/2022
1	Non-alcoholic Fatty Liver Disease 01/2022
1	Glucose Intolerance 01/2022
1	Liver Neoplasms (Liver Cancer) 05/2021
1	Neoplasm Metastasis (Metastasis) 05/2021
1	Amnesia (Dissociative Amnesia) 01/2021
1	Fibrosis (Cirrhosis) 04/2020
1	Corneal Injuries 04/2020
1	Corneal Opacity 04/2020
1	Chills 01/2020
1	Muscle Rigidity 01/2020
1	Atherosclerotic Plaque (Atheroma) 12/2019
1	Rupture 12/2019

Drug/Important Bio-Agent (IBA)

11	Proteins (Proteins, Gene)FDA Link 01/2022 - 05/2004
7	Kainic Acid (Kainate)IBA 08/2011 - 01/2003
6	LipopolysaccharidesIBA 11/2015 - 04/2005
5	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 08/2006
5	Pharmaceutical PreparationsIBA 01/2022 - 03/2015
5	CytokinesIBA 01/2022 - 08/2004
5	SP-8356IBA 05/2021 - 01/2019
5	AntioxidantsIBA 03/2013 - 01/2004
4	Matrix Metalloproteinases (MMPs)IBA 01/2022 - 07/2008
4	verbenoneIBA 01/2022 - 01/2019
4	Neuroprotective AgentsIBA 01/2020 - 09/2004
4	Dextromethorphan (Racemethorphan)FDA LinkGeneric 12/2006 - 01/2003
3	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2022 - 03/2015
3	Oxygen (Dioxygen)IBA 01/2022 - 08/2006
3	Metalloproteases (Metalloproteinases)IBA 01/2022 - 05/2017
3	CalpainIBA 01/2020 - 07/2006
3	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2019 - 10/2005
3	DNA (Deoxyribonucleic Acid)IBA 03/2007 - 01/2004
2	otaplimastatIBA 01/2022 - 01/2020
2	C-Reactive ProteinIBA 01/2022 - 08/2012
2	Therapeutic UsesIBA 01/2022 - 01/2017
2	NF-kappa B (NF-kB)IBA 05/2021 - 01/2007
2	Mitogen-Activated Protein KinasesIBA 05/2021 - 01/2006
2	Immunoglobulins (Immunoglobulin)IBA 04/2020 - 01/2019
2	Cyclophilin AIBA 12/2019 - 01/2017
2	Vitamin D FDA LinkGeneric 01/2019 - 01/2017
2	Biomarkers (Surrogate Marker)IBA 01/2017 - 08/2012
2	Simvastatin (Zocor)FDA LinkGeneric 11/2015 - 04/2006
2	Dihydrotachysterol (AT 10)IBA 03/2015 - 05/2004
2	trimethyltinIBA 06/2013 - 08/2011
2	Interleukin-6 (Interleukin 6)IBA 06/2013 - 08/2012
2	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 06/2013 - 08/2006
2	3-nitrotyrosineIBA 04/2013 - 04/2005
2	Free RadicalsIBA 03/2013 - 08/2011
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2012 - 04/2006
2	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 06/2012 - 12/2006
2	GinsenosidesIBA 02/2009 - 01/2009
2	Malondialdehyde (Propanedial)IBA 05/2008 - 05/2004
2	Cysteine (L-Cysteine)FDA Link 09/2006 - 08/2006
2	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 01/2006 - 01/2004
2	Phorbol EstersIBA 01/2006 - 10/2005
2	CalciumIBA 06/2005 - 10/2004
2	CalbindinsIBA 06/2005 - 10/2004
2	dimemorfan (AT 17)IBA 04/2005 - 05/2004
2	DextrorphanIBA 05/2004 - 01/2003
1	QuinazolinesIBA 01/2022
1	Tissue Inhibitor of MetalloproteinasesIBA 01/2022
1	Insulin (Novolin)FDA Link 01/2022
1	HemoHIMIBA 01/2021
1	Scopolamine (Hyoscine)FDA Link 01/2021
1	AlkaliesIBA 04/2020
1	Apolipoproteins E (ApoE)IBA 12/2019
1	LipidsIBA 12/2019

Therapy/Procedure

4	Therapeutics 06/2016 - 08/2010
3	Ligation 01/2019 - 01/2006
2	Stents 01/2019 - 01/2017
1	Treatment Delay 01/2022
1	Drug Therapy (Chemotherapy) 05/2021